Bank of New York Mellon’s VistaGen Therapeutics VTGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-15,171
| Closed | -$78K | – | 4311 |
|
|
2023
Q4 | $78K | Buy |
+15,171
| New | +$78K | ﹤0.01% | 4119 |
|
|
2023
Q2 | – | Sell |
-19,303
| Closed | -$72.2K | – | 4453 |
|
|
2023
Q1 | $72.2K | Hold |
19,303
| – | – | ﹤0.01% | 4124 |
|
|
2022
Q4 | $59.6K | Hold |
19,303
| – | – | ﹤0.01% | 4209 |
|
|
2022
Q3 | $88K | Sell |
19,303
-4,502
| -19% | -$20.5K | ﹤0.01% | 4221 |
|
|
2022
Q2 | $628K | Sell |
23,805
-1,823
| -7% | -$48.1K | ﹤0.01% | 3450 |
|
|
2022
Q1 | $954K | Sell |
25,628
-1,478
| -5% | -$55K | ﹤0.01% | 3350 |
|
|
2021
Q4 | $1.59M | Buy |
27,106
+7,327
| +37% | +$428K | ﹤0.01% | 3131 |
|
|
2021
Q3 | $1.63M | Buy |
19,779
+4,148
| +27% | +$341K | ﹤0.01% | 3113 |
|
|
2021
Q2 | $1.48M | Buy |
15,631
+13,537
| +646% | +$1.28M | ﹤0.01% | 3187 |
|
|
2021
Q1 | $134K | Buy |
2,094
+171
| +9% | +$10.9K | ﹤0.01% | 4123 |
|
|
2020
Q4 | $112K | Buy |
+1,923
| New | +$112K | ﹤0.01% | 4059 |
|